Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction

New England Journal of Medicine

Volumn 334, Issue 1, 1996, Pages 7-12

  Andreotti, Felicita ^a   Pasceri, Vincenzo ^a   Hackett, David R ^b   Davies, Graham J ^b   Haider, Agha W ^b   Maseri, Attilio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPERFUSION;

ADULT; AGED; ANGINA, UNSTABLE; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLASMINOGEN ACTIVATORS; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0030031272     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199601043340102     Document Type: Article

References (40)

1. Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? Circulation 1995;91:37-47.
2. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995;91:291-7.
3. Kloner RA, Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol 1994;24:1133-42.
4. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980,303:897-902
5. Davies MJ, Thomas AC. Thrombosis and acute coronary lesions in sudden ischemic death N Engl J Med 1984;310:1137-40
6. Lincoff AM, Topol EJ. Illusion of reperfusion: does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993;87:1792-805.
7. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22.
8. Collen D. Coronary thrombolysis: streptokinase or recombinant tissue-type plasminogen activator? Ann Intern Med 1990;112:529-38.
9. Kunitada S, FitzGerald GA, Fitzgerald DJ Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction. Blood 1992;79:1420-7.
10. Jang JK, Gold HK, Ziskind AA, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator a possible explanation for resistance to coronary thrombolysis. Circulation 1989;79:920-8.
11. Fox KA, Robison AK, Knabb RM, Rosamond TL, Sobel BE, Bergmann SR. Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator. Circulation 1985;72.1346-54.
12. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990;10:240-5.
13. Potter van Loon BJ, Rijken DC, Brommer EJP, van der Maas APC. The amount of plasminogen, tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility. Thromb Haemost 1992,67.101-5.
14. Braunwald E. Morning resistance to thrombolytic therapy. Circulation 1995,91 1604-6.
15. Khan MI, Hackett DR, Andreotti F, et al Effectiveness of multiple bolus administration of tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol 1990;65.1051-6
16. Beebe DP, Aronson DL. An automated fibrinolytic assay performed in microtiter plates. Thromb Res 1987;47.123-8.
17. The TIMI Study Group. The thrombolysis m myocardial infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-6.
18. Karagounis L, Sorensen SG, Menlove RL, Moreno F, Anderson JL. Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study: second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. J Am Coll Cardiol 1992;19:1-10.
19. Vogt A, von Essen R, Tebbe U, Feuerer W, Appel KF, Neuhaus KL. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. J Am Coll Cardiol 1993,21 1391-5.
20. Grande P, Hansen BF, Christiansen C, Naestoft J. Estimation of acute myocardial infarct size in man by serum CK-MB measurements. Circulation 1982;65:756-64.
21. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-46
22. Ingerslev J A sensitive ELISA for von Willebrand factor (vWf:Ag). Scand J Clin Lab Invest 1987;47-143-9.
23. Harper RW, Kennedy G, DeSanctis RW, Hutter AM Jr. The incidence and pattern of angina prior to acute myocardial infarction: a study of 577 cases. Am Heart J 1979;97:178-83.
24. Cox DR, Hinkley DV. Theoretical statistics. London: Chapman & Hall, 1974.
25. Hackett D, Davies G, Chierchia S, Maseri A Intermittent coronary occlusion in acute myocardial infarction: value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987,317:1055-9.
26. Davies GJ, Chierchia S, Maseri A. Prevention of myocardial infarction by very early treatment with intracoronary streptokinase some clinical observations. N Engl J Med 1984;311:1488-92.
27. Kagen L, Scheidt S, Butt A. Serum myoglobin in myocardial infarction: the "staccato phenomenon": is acute myocardial infarction in man an intermittent event? Am J Med 1977,62.86-92.
28. Falk E. Unstable angina with fatal outcome, dynamic coronary thrombosis leading to infarction and/or sudden death: autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699-708.
29. Salazar AE. Experimental myocardial infarction: induction of coronary thrombosis in the intact closed-chest dog Circ Res 1961;9:1351-6.
30. Liuzzo G, Biasucci LM, Gallimore JR, et al The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
31. Walker AM Low power and striking results - a surprise but not a paradox. N Engl J Med 1995;332:1091-2.
32. Ridker PM. Plasma concentration of endogenous tissue plasminogen activator and the occurrence of future cardiovascular events J Thromb Thrombolysis 1994;1:35-40.
33. Braunwald E, Kloner RA The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982,66:1146-9.
34. Matsuda Y, Ogawa H, Moritani K, et al. Effects of the presence or absence of preceding angina pectoris on left ventricular function after acute myocardial infarction. Am Heart J 1984;108:955-8
35. Fujita M, Sasayama S, Ohno A, Nakajima H, Asanoi H. Importance of angina for development of collateral circulation. Br Heart J 1987;57:139-43.
36. Muller DWM, Topol EJ, Califf RM, et al. Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Am Heart J 1990;119:224-31.
37. Pasceri V, Cianflone D, Finocchiaro ML, Crea F, Maseri A Relation between myocardial infarction site and pain location in Q-wave acute myocardial infarction. Am J Cardiol 1995;75:224-7
38. Pierard LA, Dubois C, Smeets JP, Boland J, Carlier J, Kulbertus HE. Prognostic significance of angina pectoris before first acute myocardial infarction. Am J Cardiol 1988;61:984-7
39. Ruocco NA Jr, Bergelson BA, Jacobs AK, Frederick MM, Faxon DP, Ryan TJ. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina: a report from Thrombolysis in Myocardial Infarction Phase II (TIMI II). J Am Coll Cardiol 1992;20:1445-51.
40. Barbash GI, White HD, Modan M, Van de Werf F. Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Actrvator/Streptokinase Mortality Trial. J Am Coll Cardiol 1992;20:36-41